z-logo
open-access-imgOpen Access
Involvement of Matrix Metalloproteinases in Human Immunodeficiency Virus Type 1–Induced Replication by ClinicalMycobacterium aviumIsolates
Author(s) -
Charlene S. Dezzutti,
W. Edward Swords,
Patricia C. Guenthner,
Donna R. Sasso,
Larry M. Wahl,
Alan H. Drummond,
G W Newman,
C. Harold King,
Frederick D. Quinn,
Renu B. Lal
Publication year - 1999
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/314992
Subject(s) - biology , virology , viral replication , matrix metalloproteinase , virus , microbiology and biotechnology , in vitro , serotype , protease , mycobacterium , enzyme , bacteria , genetics , biochemistry
The role of Mycobacterium avium isolates in modulating human immunodeficiency virus type 1 (HIV-1) replication was examined by use of an in vitro, resting T cell system. Two human clinical isolates (serotypes 1 and 4) but not an environmental M. avium isolate (serotype 2) enhanced HIV-1 replication. The M. avium-induced HIV-1 replication was not associated with cell activation or differential cytokine production or utilization. Addition of matrix metalloproteinase (MMP) inhibitors and their in vivo regulators, tissue inhibitors of metalloproteinases-1 and -2, abrogated M. avium-induced HIV-1 replication 80%-95%. The MMP inhibitors did not have any effect on the HIV-1 protease activity, suggesting that they may affect cellular processes. Furthermore, MMP-9 protein was differentially expressed after infection with clinical M. avium isolates and paralleled HIV-1 p24 production. Collectively, these data suggest that M. avium-induced HIV-1 replication is mediated, in part, through the induction of MMP-9.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom